ASB5
gene geneOn this page
Summary
ASB5 (ankyrin repeat and SOCS box containing 5, HGNC:17180) is a protein-coding gene on chromosome 4q34.2, encoding Ankyrin repeat and SOCS box protein 5 (Q8WWX0). May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
The protein encoded by this gene is a member of the ankyrin repeat and SOCS box-containing (ASB) family of proteins. They contain ankyrin repeat sequence and SOCS box domain. The SOCS box serves to couple suppressor of cytokine signalling (SOCS) proteins and their binding partners with the elongin B and C complex, possibly targeting them for degradation. Multiple alternatively spliced transcript variants have been described for this gene but their full length sequences are not known.
Source: NCBI Gene 140458 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 62 total
- GTEx eGene: eQTL in 24 tissues, sQTL in 2 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.32 (unconstrained)
- MANE Select transcript:
NM_080874 - Notable: 62 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17180 |
| Approved symbol | ASB5 |
| Name | ankyrin repeat and SOCS box containing 5 |
| Location | 4q34.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000164122 |
| Ensembl biotype | protein_coding |
| OMIM | 615050 |
| Entrez | 140458 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 12 protein_coding, 2 protein_coding_CDS_not_defined
MANE Select: ENST00000296525
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 1, TSL 3: 1, TSL 4: 1, TSL 5: 1
ENST00000296525, ENST00000505299, ENST00000510578, ENST00000511879, ENST00000512254, ENST00000672074, ENST00000855722, ENST00000855723, ENST00000855724, ENST00000945694, ENST00000945695, ENST00000945696, ENST00001116135, ENST00001140398
RefSeq mRNA: 2 — MANE Select: NM_080874
NM_001410863, NM_080874
CCDS: CCDS3827, CCDS93672
Canonical transcript exons
ENST00000296525 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001081665 | 176221450 | 176221600 |
| ENSE00001081666 | 176221155 | 176221289 |
| ENSE00001081670 | 176268913 | 176269222 |
| ENSE00001254223 | 176216818 | 176217009 |
| ENSE00001254259 | 176213673 | 176215727 |
| ENSE00003502184 | 176222313 | 176222420 |
| ENSE00003603238 | 176225262 | 176225341 |
Expression profiles
Bgee: expression breadth ubiquitous, 167 present calls, max score 99.54.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 6.8289 / max 1128.4699, expressed in 162 samples.
Highest expression (Bgee): skeletal muscle tissue of rectus abdominis, deltoid, quadriceps femoris, tibialis anterior, vastus lateralis.
Genetic regulation across tissues (GTEx eQTL / sQTL)
ASB5 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 24 tissues and its splicing (sQTL) in 2 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 26 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Brain Spinal cord cervical c-1 | eqtl | 1.5e-33 | +1.02 | 4:176234637:C:A |
| Esophagus Muscularis | eqtl | 3.1e-26 | +0.40 | 4:176265731:T:C |
| Heart Atrial Appendage | eqtl | 3.9e-24 | +0.49 | 4:176231013:C:A |
| Heart Left Ventricle | eqtl | 4.2e-23 | +0.43 | 4:176232708:T:C |
| Brain Putamen basal ganglia | eqtl | 1.4e-22 | +0.82 | 4:176230252:C:A |
| Pituitary | eqtl | 8.5e-22 | +0.63 | 4:176223624:T:A |
| Brain Nucleus accumbens basal ganglia | eqtl | 1.7e-19 | +0.69 | 4:176231716:C:T |
| Brain Cerebellum | eqtl | 2.2e-18 | +0.79 | 4:176230252:C:A |
| Brain Substantia nigra | eqtl | 3.5e-17 | +0.75 | 4:176230252:C:A |
| Brain Caudate basal ganglia | eqtl | 5.9e-16 | +0.63 | 4:176229774:A:G |
| Brain Hypothalamus | eqtl | 7.6e-14 | +0.63 | 4:176229774:A:G |
| Brain Cerebellar Hemisphere | eqtl | 7.4e-13 | +0.62 | 4:176230252:C:A |
| Muscle Skeletal | sqtl | 1.2e-12 | +0.30 | 4:176224561:T:C |
| Brain Cortex | eqtl | 2.3e-10 | +0.61 | 4:176234637:C:A |
| Brain Hippocampus | eqtl | 4.3e-09 | +0.58 | 4:176229774:A:G |
| Esophagus Gastroesophageal Junction | eqtl | 8.9e-09 | +0.26 | 4:176266957:A:G |
| Testis | sqtl | 2.9e-08 | -1.05 | 4:176305285:C:A |
| Brain Frontal Cortex BA9 | eqtl | 2.2e-07 | +0.48 | 4:176229774:A:G |
| Brain Anterior cingulate cortex BA24 | eqtl | 5.3e-07 | +0.57 | 4:176231716:C:T |
| Cells Cultured fibroblasts | eqtl | 6.1e-07 | -0.23 | 4:176269644:T:TA |
FANTOM5 promoters
7 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 55032 | 5.9475 | 148 |
| 55030 | 0.4764 | 98 |
| 55031 | 0.3030 | 89 |
| 55029 | 0.0579 | 28 |
| 55033 | 0.0196 | 10 |
| 55034 | 0.0176 | 5 |
| 55028 | 0.0069 | 3 |
Top tissues by expression
showing 100 of 246 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 99.54 | gold quality |
| deltoid | UBERON:0001476 | 99.33 | gold quality |
| quadriceps femoris | UBERON:0001377 | 99.31 | gold quality |
| tibialis anterior | UBERON:0001385 | 99.31 | gold quality |
| vastus lateralis | UBERON:0001379 | 99.29 | gold quality |
| biceps brachii | UBERON:0001507 | 99.20 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 99.08 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 98.90 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 97.87 | gold quality |
| body of tongue | UBERON:0011876 | 97.56 | gold quality |
| gastrocnemius | UBERON:0001388 | 97.15 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 95.94 | gold quality |
| muscle of leg | UBERON:0001383 | 95.10 | gold quality |
| muscle tissue | UBERON:0002385 | 90.74 | gold quality |
| tongue | UBERON:0001723 | 90.65 | gold quality |
| parotid gland | UBERON:0001831 | 89.01 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.32 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.75 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 81.13 | gold quality |
| lower esophagus | UBERON:0013473 | 80.99 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 80.92 | gold quality |
| superior surface of tongue | UBERON:0007371 | 79.93 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 79.85 | gold quality |
| mucosa of stomach | UBERON:0001199 | 78.82 | gold quality |
| urethra | UBERON:0000057 | 74.06 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 73.81 | gold quality |
| urinary bladder | UBERON:0001255 | 72.80 | gold quality |
| prostate gland | UBERON:0002367 | 71.31 | gold quality |
| left testis | UBERON:0004533 | 69.26 | gold quality |
| right testis | UBERON:0004534 | 68.26 | gold quality |
| fundus of stomach | UBERON:0001160 | 67.58 | gold quality |
| testis | UBERON:0000473 | 66.62 | gold quality |
| heart left ventricle | UBERON:0002084 | 66.47 | gold quality |
| esophagus | UBERON:0001043 | 66.23 | gold quality |
| cardiac ventricle | UBERON:0002082 | 66.07 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 65.96 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 64.50 | gold quality |
| right atrium auricular region | UBERON:0006631 | 63.82 | gold quality |
| cardiac atrium | UBERON:0002081 | 62.94 | gold quality |
| heart | UBERON:0000948 | 62.62 | gold quality |
| spinal cord | UBERON:0002240 | 62.62 | gold quality |
| colon | UBERON:0001155 | 62.23 | gold quality |
| gall bladder | UBERON:0002110 | 61.75 | gold quality |
| large intestine | UBERON:0000059 | 61.64 | gold quality |
| rectum | UBERON:0001052 | 61.11 | gold quality |
| minor salivary gland | UBERON:0001830 | 60.53 | gold quality |
| colonic epithelium | UBERON:0000397 | 59.85 | silver quality |
| mouth mucosa | UBERON:0003729 | 59.10 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 58.78 | gold quality |
| endothelial cell | CL:0000115 | 58.36 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 58.08 | gold quality |
| intestine | UBERON:0000160 | 57.92 | gold quality |
| synovial joint | UBERON:0002217 | 57.89 | gold quality |
| substantia nigra | UBERON:0002038 | 57.76 | gold quality |
| jejunum | UBERON:0002115 | 57.55 | gold quality |
| prefrontal cortex | UBERON:0000451 | 57.23 | gold quality |
| vermiform appendix | UBERON:0001154 | 57.10 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 56.59 | gold quality |
| oral cavity | UBERON:0000167 | 55.87 | gold quality |
| midbrain | UBERON:0001891 | 55.70 | gold quality |
| transverse colon | UBERON:0001157 | 55.49 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 55.30 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 54.67 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| apex of heart | UBERON:0002098 | 54.32 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| cardia of stomach | UBERON:0001162 | 53.78 | gold quality |
| amygdala | UBERON:0001876 | 53.56 | gold quality |
| ectocervix | UBERON:0012249 | 53.53 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| caecum | UBERON:0001153 | 53.36 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 53.21 | gold quality |
| islet of Langerhans | UBERON:0000006 | 53.09 | gold quality |
| stomach | UBERON:0000945 | 52.95 | gold quality |
| esophagus mucosa | UBERON:0002469 | 52.77 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 52.69 | gold quality |
| endocervix | UBERON:0000458 | 52.65 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 52.39 | gold quality |
| lower lobe of lung | UBERON:0008949 | 52.34 | silver quality |
| neocortex | UBERON:0001950 | 51.58 | gold quality |
| putamen | UBERON:0001874 | 51.51 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 51.46 | gold quality |
| frontal cortex | UBERON:0001870 | 51.41 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 51.20 | gold quality |
| body of stomach | UBERON:0001161 | 51.15 | gold quality |
| caudate nucleus | UBERON:0001873 | 51.10 | gold quality |
| tonsil | UBERON:0002372 | 50.67 | gold quality |
| anatomical system | UBERON:0000467 | 50.48 | gold quality |
| multicellular organism | UBERON:0000468 | 50.36 | gold quality |
| material anatomical entity | UBERON:0000465 | 50.35 | gold quality |
| uterine cervix | UBERON:0000002 | 50.09 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 50.03 | silver quality |
| cerebral cortex | UBERON:0000956 | 49.61 | gold quality |
| nucleus accumbens | UBERON:0001882 | 49.27 | gold quality |
| forebrain | UBERON:0001890 | 49.06 | gold quality |
| right frontal lobe | UBERON:0002810 | 49.00 | gold quality |
| brain | UBERON:0000955 | 48.97 | gold quality |
| stromal cell of endometrium | CL:0002255 | 48.94 | gold quality |
| cerebellar vermis | UBERON:0004720 | 48.63 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.99 |
HPA expression
RNA tissue specificity: Group enriched
showing 60 of 61 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Skeletal muscle | tissue | 203.4 |
| Tongue | tissue | 62.7 |
| Salivary gland | tissue | 22.5 |
| Urinary bladder | tissue | 14.1 |
| Corpus callosum | tissue | 13.8 |
| Spinal cord | tissue | 13.1 |
| Prostate | tissue | 12.0 |
| Midbrain | tissue | 11.9 |
| Hypothalamus | tissue | 11.9 |
| Superior colliculi | tissue | 11.6 |
| Substantia nigra | tissue | 11.6 |
| Septum | tissue | 11.5 |
| Hippocampal formation | tissue | 11.4 |
| Cerebral cortex | tissue | 11.1 |
| Motor cortex | tissue | 11.1 |
| Thalamus | tissue | 11.0 |
| Putamen | tissue | 10.8 |
| Retrosplenial and cingulate cortex | tissue | 10.8 |
| Temporal cortex | tissue | 10.7 |
| Entorhinal cortex | tissue | 10.6 |
| Retrosplenial cortex | tissue | 10.6 |
| Amygdala | tissue | 10.5 |
| Ventral forebrain | tissue | 10.5 |
| Periaqueductal gray | tissue | 10.5 |
| Pons | tissue | 10.4 |
| Medulla oblongata | tissue | 10.4 |
| Prefrontal cortex | tissue | 10.2 |
| Insular cortex | tissue | 10.2 |
| Basal ganglia | tissue | 10.1 |
| Esophagus | tissue | 9.9 |
| Somatosensory cortex | tissue | 9.9 |
| Occipital cortex | tissue | 9.7 |
| Cerebellum | tissue | 9.6 |
| Olfactory bulb | tissue | 9.5 |
| Testis | tissue | 4.3 |
| Heart muscle | tissue | 3.6 |
| Rectum | tissue | 3.1 |
| Smooth muscle | tissue | 2.3 |
| Frontal cortex | tissue | 1.5 |
| Colon | tissue | 1.3 |
| Gallbladder | tissue | 1.1 |
| Caudate putamen | tissue | 0.9 |
| Vagina | tissue | 0.8 |
| Appendix | tissue | 0.8 |
| Kidney | tissue | 0.7 |
| Locus coeruleus | tissue | 0.7 |
| Endometrium 1 | tissue | 0.6 |
| Cervix | tissue | 0.4 |
| Pituitary gland | tissue | 0.4 |
| Seminal vesicle | tissue | 0.3 |
| Nucleus accumbens | tissue | 0.3 |
| Duodenum | tissue | 0.3 |
| Hippocampus | tissue | 0.3 |
| Postcentral gyrus | tissue | 0.3 |
| Stomach 1 | tissue | 0.2 |
| Lung | tissue | 0.2 |
| Small intestine | tissue | 0.2 |
| Parathyroid gland | tissue | 0.1 |
| Epididymis | tissue | 0.1 |
| Choroid plexus | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 188; highest nTPM — White matter (13.8), Dorsal spinal cord (13.1), Ventral spinal cord (11.7), Subiculum (11.4), Dorsal hippocampus (11.3).
Regulation
Is transcription factor: no
Functional genomics
gnomAD constraint: pLI 2.46e-14, LOEUF 1.32, missense Z 0.28 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000296525 — one region, missense o/e 1.01.
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Asb5 | ENSMUSG00000031519 |
| rattus_norvegicus | Asb5 | ENSRNOG00000042630 |
Paralogs (2): ASB9 (ENSG00000102048), ASB11 (ENSG00000165192)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1923544) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 5 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| abnormal vertebrae morphology | 1 |
| abnormal thymus morphology | 1 |
| enlarged thymus | 1 |
| increased circulating potassium level | 1 |
| decreased circulating sodium level | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Latrodectus tredecimguttatus | Q02989 | 100.0% | Diamond |
| Macaca fascicularis | Q9BGT9 | 99.7% | Diamond |
| Pongo abelii | Q5RCK5 | 99.4% | Diamond |
| Oryctolagus cuniculus | Q862Z2 | 94.8% | Diamond |
| Bos taurus | Q17QS6 | 92.1% | Diamond |
| Danio rerio | Q70X92 | 57.8% | Diamond |
| Fowlpox virus strain NVSL | Q9J4Z4 | 52.8% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| SPCS3-AS1 | ncRNA | 116435303 |
| SPATA4 | protein-coding | 132851 |
| SPCS3 | protein-coding | 60559 |
| GPM6A | protein-coding | 2823 |
| WDR17 | protein-coding | 116966 |
| HAFML | ncRNA | 105377555 |
| VEGFC | protein-coding | 7424 |
Protein
Protein identifiers
Ankyrin repeat and SOCS box protein 5 — Q8WWX0 (reviewed: Q8WWX0)
All UniProt accessions (4): Q8WWX0, A0A5F9ZHS2, D6R9Q2, Q5HYF3
UniProt curated annotations — full annotation on UniProt →
Function. May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. May play a role in the initiation of arteriogenesis.
Domain organisation. The SOCS box domain mediates the interaction with the Elongin BC complex, an adapter module in different E3 ubiquitin-protein ligase complexes.
Pathway. Protein modification; protein ubiquitination.
Similarity. Belongs to the ankyrin SOCS box (ASB) family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WWX0-1 | 1 | yes |
| Q8WWX0-2 | 2 |
RefSeq proteins (2): NP_001397792, NP_543150* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001496 | SOCS_box | Domain |
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR036036 | SOCS_box-like_dom_sf | Homologous_superfamily |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR037328 | ASB5_SOCS | Domain |
| IPR051573 | Ankyrin-SOCS_box_domain | Family |
Pfam: PF07525, PF12796
UniProt features (9 total): repeat 6, chain 1, domain 1, splice variant 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WWX0-F1 | 85.93 | 0.60 |
Human Protein Atlas
Protein class: Predicted membrane proteins, Predicted intracellular proteins, UniProt - Evidence at transcript level
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): plasma membrane
Antibody reliability (HPA): IF approved
Function
Pathways and Gene Ontology
Reactome pathways
2 curated (TAS) of 7; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
7 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | curated |
| R-HSA-8951664 | Neddylation | curated |
| R-HSA-1280218 | Adaptive Immune System | — |
| R-HSA-983169 | Class I MHC mediated antigen processing & presentation | — |
| R-HSA-168256 | Immune System | — |
| R-HSA-392499 | Metabolism of proteins | — |
| R-HSA-597592 | Post-translational protein modification | — |
MSigDB gene sets: 101 (showing top):
AP1_01, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION, REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION, GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, chr4q34, GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP, AP4_Q6, CAGCTG_AP4_Q5, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS, MODULE_285, GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS, TGANTCA_AP1_C
GO Biological Process (3): protein ubiquitination (GO:0016567), intracellular signal transduction (GO:0035556), positive regulation of protein catabolic process (GO:0045732)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): cytosol (GO:0005829)
Reactome top-level categories
5 top-level categories:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
| Class I MHC mediated antigen processing & presentation | 1 |
| Immune System | 1 |
| Metabolism of proteins | 1 |
| Adaptive Immune System | 1 |
GO top-level categories
10 GO namespaces:
| Category | Terms |
|---|---|
| protein modification by small protein conjugation | 1 |
| intracellular anatomical structure | 1 |
| signal transduction | 1 |
| positive regulation of catabolic process | 1 |
| protein catabolic process | 1 |
| regulation of protein catabolic process | 1 |
| positive regulation of protein metabolic process | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
showing 15 of 784 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ASB5 | SPCS3 | P12280 | 594 |
| ASB5 | WDR17 | Q8IZU2 | 492 |
| ASB5 | CARD19 | Q96LW7 | 475 |
| ASB5 | NEURL2 | Q9BR09 | 473 |
| ASB5 | ABTB1 | Q969K4 | 453 |
| ASB5 | PNMA1 | Q8ND90 | 449 |
| ASB5 | ASB6 | Q9NWX5 | 446 |
| ASB5 | SPATA4 | Q8NEY3 | 415 |
| ASB5 | KRTAP4-16 | G5E9R7 | 400 |
| ASB5 | RASSF9 | O75901 | 393 |
| ASB5 | LRRC30 | A6NM36 | 371 |
| ASB5 | FBXO7 | Q9Y3I1 | 370 |
| ASB5 | CTXND1 | A0A1B0GTU2 | 362 |
| ASB5 | IRAG1 | Q9Y6F6 | 362 |
| ASB5 | PNMA2 | Q9UL42 | 357 |
IntAct
BioGRID (23 interactions; top human partners by supporting records): AKR1B1 (Affinity Capture-MS), ASB1 (Affinity Capture-MS), ATP2A2 (Affinity Capture-MS), ATP5B (Affinity Capture-MS), ATP5C1 (Affinity Capture-MS), BSG (Affinity Capture-MS), CRYAB (Affinity Capture-MS), CUL5 (Affinity Capture-MS), DNAJA1 (Affinity Capture-MS), ENO2 (Affinity Capture-MS), GCN1L1 (Affinity Capture-MS), HIF1AN (Affinity Capture-MS), LRPPRC (Affinity Capture-MS), PPP2CB (Affinity Capture-MS), PRKDC (Affinity Capture-MS)
Disease & clinical
Genetic variants
Variant evidence for ASB5: 62 ClinVar records (0 pathogenic / likely pathogenic); 1 GWAS association.
ClinVar
62 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 1 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 33 predictions of 429):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 4:176221448–176221449 | donor_loss | 1.0000 | 5 |
| 4:176225261 | donor_loss | 1.0000 | 2 |
| 4:176225342–176225343 | acceptor_loss | 1.0000 | 6 |
| 4:176268911–176268912 | donor_loss | 1.0000 | 5 |
| 4:176216816–176216817 | donor_loss | 0.9900 | 4 |
| 4:176217010–176217011 | acceptor_loss | 0.9900 | 6 |
| 4:176217014–176217016 | acceptor_gain | 0.9900 | 2 |
| 4:176217023 | acceptor_gain | 0.9900 | |
| 4:176217026 | acceptor_gain | 0.9900 | |
| 4:176221448 | donor_loss | 0.9900 |
AlphaMissense
763 missense substitutions predicted likely pathogenic (of 2,123 scored), across 208 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| H108 | 8 | 0.953 | 0.986 |
| H75 | 8 | 0.942 | 0.973 |
| F25 | 8 | 0.939 | 0.988 |
| D102 | 8 | 0.914 | 0.956 |
| N47 | 8 | 0.869 | 0.986 |
| F27 | 8 | 0.867 | 0.977 |
| H238 | 8 | 0.860 | 0.950 |
| D70 | 8 | 0.843 | 0.938 |
| H173 | 8 | 0.843 | 0.962 |
| F30 | 8 | 0.834 | 0.910 |
| E50 | 7 | 0.966 | 0.988 |
| F41 | 7 | 0.914 | 0.987 |
| F141 | 7 | 0.906 | 0.984 |
| W68 | 7 | 0.905 | 0.973 |
| R53 | 7 | 0.903 | 0.977 |
| F58 | 7 | 0.879 | 0.986 |
| C118 | 7 | 0.871 | 0.993 |
| H40 | 7 | 0.862 | 0.959 |
| C144 | 7 | 0.862 | 0.996 |
| F325 | 7 | 0.857 | 0.965 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Kidney Chromophobe)
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
1 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Head and Neck Squamous Cell Carcinoma (TCGA) | unfavorable | 0.000116 |
Disease associations
OMIM: gene MIM:615050 | disease phenotypes:
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST009391_413 | Metabolite levels | 5e-6 |
EFO canonical traits (from GWAS)
1 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0010437 | triacylglycerol 58:10 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases methylation, increases expression | 2 |
| Valproic Acid | decreases methylation, increases expression | 2 |
| 2-methyl-4-isothiazolin-3-one | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Arsenic Trioxide | decreases expression | 1 |
| Polychlorinated Biphenyls | affects expression | 1 |
| Smoke | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.